Literature DB >> 21411985

Expansion of CD56-negative, CD16-positive, KIR-expressing natural killer cells after T cell-depleted haploidentical hematopoietic stem cell transplantation.

Claudia De Angelis1, Antonella Mancusi, Loredana Ruggeri, Marusca Capanni, Elena Urbani, Andrea Velardi, Martin Stern.   

Abstract

The main functions of natural killer (NK) cells are early protection against viruses or tumor cells and production of cytokines that regulate immune functions. The present study assessed the role of different NK subsets in exerting graft-versus-leukemia effects in recipients of human leukocyte antigen (HLA) haploidentical hematopoietic transplants and monitored for the first time CD3-/CD56- lymphocyte expansion. CD3-/CD56- cells expressed NK cell-associated molecules, such as CD16, NKp46, NKp30, CD244 (2B4), CD161, and killer cell immunoglobulin-like receptors. CD3-/CD56- cells further exhibited the classical functional characteristics of NK cells: cytolysis of target cells lacking HLA class I, antibody-dependent cellular cytotoxicity and cytokine production. These results demonstrate that CD56- NK cells are functional, recognize missing self and, like their CD56+ counterparts, may contribute to graft-versus-leukemia reactions.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21411985     DOI: 10.1159/000323661

Source DB:  PubMed          Journal:  Acta Haematol        ISSN: 0001-5792            Impact factor:   2.195


  8 in total

1.  A novel method to expand large numbers of CD56(+) natural killer cells from a minute fraction of selectively accessed cryopreserved cord blood for immunotherapy after transplantation.

Authors:  Sumithira Vasu; Maria Berg; Jan Davidson-Moncada; Xin Tian; Herb Cullis; Richard W Childs
Journal:  Cytotherapy       Date:  2015-11       Impact factor: 5.414

2.  Single-cell profiling identifies impaired adaptive NK cells expanded after HCMV reactivation in haploidentical HSCT.

Authors:  Elisa Zaghi; Michela Calvi; Simone Puccio; Gianmarco Spata; Sara Terzoli; Clelia Peano; Alessandra Roberto; Federica De Paoli; Jasper Jp van Beek; Jacopo Mariotti; Chiara De Philippis; Barbara Sarina; Rossana Mineri; Stefania Bramanti; Armando Santoro; Vu Thuy Khanh Le-Trilling; Mirko Trilling; Emanuela Marcenaro; Luca Castagna; Clara Di Vito; Enrico Lugli; Domenico Mavilio
Journal:  JCI Insight       Date:  2021-06-22

3.  Healthy Neonates Possess a CD56-Negative NK Cell Population with Reduced Anti-Viral Activity.

Authors:  Amanda Jacobson; Frank Bell; Nicholas Lejarcegui; Caroline Mitchell; Lisa Frenkel; Helen Horton
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

Review 4.  Graft-Versus-Solid-Tumor Effect: From Hematopoietic Stem Cell Transplantation to Adoptive Cell Therapies.

Authors:  Stefan Barisic; Richard W Childs
Journal:  Stem Cells       Date:  2022-06-22       Impact factor: 5.845

Review 5.  CD56 in the Immune System: More Than a Marker for Cytotoxicity?

Authors:  Heleen H Van Acker; Anna Capsomidis; Evelien L Smits; Viggo F Van Tendeloo
Journal:  Front Immunol       Date:  2017-07-24       Impact factor: 7.561

Review 6.  Innate Immune Responses in the Outcome of Haploidentical Hematopoietic Stem Cell Transplantation to Cure Hematologic Malignancies.

Authors:  Elisa Zaghi; Michela Calvi; Clara Di Vito; Domenico Mavilio
Journal:  Front Immunol       Date:  2019-11-28       Impact factor: 7.561

Review 7.  Impact of HCMV Infection on NK Cell Development and Function after HSCT.

Authors:  Mariella Della Chiesa; Michela Falco; Letizia Muccio; Alice Bertaina; Franco Locatelli; Alessandro Moretta
Journal:  Front Immunol       Date:  2013-12-13       Impact factor: 7.561

Review 8.  Human NK Cells in Autologous Hematopoietic Stem Cell Transplantation for Cancer Treatment.

Authors:  Ane Orrantia; Iñigo Terrén; Gabirel Astarloa-Pando; Olatz Zenarruzabeitia; Francisco Borrego
Journal:  Cancers (Basel)       Date:  2021-03-30       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.